Overview

Treatment of Patients With Nocturia (Non-PK Study)

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a treatment of nocturia. The hypothesis is that SER120 will decrease the number of nocturic episodes compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Serenity Pharmaceuticals, Inc.